Business Daily Folgen

As the deaths and economic damage from Covid-19 continue to rise, Italians are asking why the EU is doing so little to help in their time of need.The pandemic is reinfecting old wounds in the EU, reopening the divide between the wealthy north and the heavily indebted south. In Italy angry citizens have taken to burning the EU flag in viral YouTube clips (pictured). There are calls for "coronabonds" to finance a rescue package for the hardest hit nations, but Germany and the Netherlands remain reticent.Business Daily's Manuela Saragosa - herself half-Italian, half-Dutch - asks journalist Antonello Guerrera of Italian newspaper La Repubblica, whether the country could turn its back on Europe. Dutch political economist Jerome Roos of the London School of Economics says the EU's future is at stake. We ask Clemens Fuest of the IFO German economics think tank whether Chancellor Angela Merkel is prepared to make an act of historic European solidarity.Producer: Laurence Knight

A vaccine is the magic bullet that would end the coronavirus pandemic, but how many months will it take to find, and will it be available to all?Justin Rowlatt speaks to a pioneering researcher of coronaviruses - not just the one behind the current Covid-19 outbreak. Susan Weiss of Pennsylvania University says the fact it was such a neglected area was one of the things that first attracted her to study these microbes. Today we know much more, but still not enough about how to inoculate against it, according to Leeds University virologist Stephen Griffin. But with dozens of medical companies now racing to find a cure, the big question is whether governments will make it available to everyone who needs it on the planet - the only certain way to defeat the pandemic - and who will pay for it? Healthcare venture capitalist Peter Kolchinsky is positive that when a vaccine is found, the businesspeople behind it will do the right thing.Producer: Laurence Knight(Picture: A researcher in Brazil works on virus replication in order to develop a Covid-19 vaccine; Credit: Douglas Magno/AFP via Getty Images)

Researchers at universities and pharmaceutical companies are rushing to identify drugs that might help cut the number of deaths from Covid-19 and take the strain of hospitals.Justin Rowlatt speaks to Richard Marsden, the chief executive of one such company, Synairgen. He hopes that a medicine his company originally developed to help asthma and flu sufferers could also now be put to use in alleviating the lung infections of Covid-19 patients.Meanwhile virologist Stephen Griffin of Leeds University in the UK explains the three main ways in which existing drugs might be used to attack the virus. Plus Theodora Bloom of the British Medical Journal tells Justin about her night job at the online research sharing server MedRxiv, which has played a central role in helping researchers get immediate access to each other's work, accelerating their response to the pandemic.Producer: Laurence Knight(Picture: Medical worker wearing protective gear treats a patient infected with the Covid-19 at the intensive care unit in Prague; Credit: Gabriel Kuchta/Getty Images)